Science Explorer Back to mapMap
Discussion
Company · Rehovot · Israel

IDEA Bio-Medical (Israel)

Research works
7
▼ 15% vs 2018-21
Citations
201
29.9 per fractional work
Top-10% rate
38.1%
all institutions 10.0%
Open access
56%
world 40%
International
36%
world 18%

Not ranked overall: IDEA Bio-Medical (Israel) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does IDEA Bio-Medical (Israel) work in?

In all years, 38% of research at IDEA Bio-Medical (Israel) is in Life Sciences, 33% in Physical Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (36%), Medicine (29%), Environmental Science (11%). It does 1.4× the world's share of Life Sciences.

Life Sciences: 3 fractional works · 38.0% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 36.4% of its workMolecular Biology: 1 fractional works · 15.8% of its workBiophysics: 1 fractional works · 14.1% of its workCell Biology: 0 fractional works · 4.9% of its workGenetics: 0 fractional works · 1.6% of its workImmunology and Microbiology: 0 fractional works · 1.6% of its workImmunology: 0 fractional works · 1.6% of its workPhysical Sciences: 2 fractional works · 33.0% of its workEnvironmental Science: 1 fractional works · 10.7% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 5.2% of its workPollution: 0 fractional works · 2.5% of its workEnvironmental Engineering: 0 fractional works · 1.9% of its workGlobal and Planetary Change: 0 fractional works · 1.0% of its workChemistry: 1 fractional works · 10.0% of its workInorganic Chemistry: 0 fractional works · 7.4% of its workAnalytical Chemistry: 0 fractional works · 2.5% of its workComputer Science: 0 fractional works · 7.4% of its workComputational Theory and Mathematics: 0 fractional works · 7.4% of its workEarth and Planetary Sciences: 0 fractional works · 3.7% of its workGeophysics: 0 fractional works · 3.7% of its workEngineering: 0 fractional works · 1.2% of its workElectrical and Electronic Engineering: 0 fractional works · 1.0% of its workBiomedical Engineering: 0 fractional works · 0.3% of its workHealth Sciences: 2 fractional works · 28.8% of its workMedicine: 2 fractional works · 28.8% of its workPharmacology: 1 fractional works · 12.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 2.8% of its workEpidemiology: 0 fractional works · 2.8% of its workOncology: 0 fractional works · 2.7% of its workSurgery: 0 fractional works · 2.7% of its workHepatology: 0 fractional works · 1.6% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.6% of its workPhysiology: 0 fractional works · 1.2% of its workNeurology: 0 fractional works · 1.0% of its workSocial Sciences: 0 fractional works · 0.1% of its workDecision Sciences: 0 fractional works · 0.1% of its workALL ITS WORKIDEA Bio-Medical(Israel)7fractional works, all years
Life Sciences38%Physical Sciences33%Health Sciences29%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology236.4%
    2. Immunology and Microbiology01.6%
    1. Environmental Science110.7%
    2. Chemistry110.0%
    3. Computer Science07.4%
    4. Earth and Planetary Sciences03.7%
    5. Engineering01.2%
    1. Medicine228.8%
    1. Decision Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from IDEA Bio-Medical (Israel)?

The most cited paper from IDEA Bio-Medical (Israel) is "Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome*" (Roman Mylonas, Ilan Beer, Christian Iseli et al., 2018), with 98 citations. Next come "Early detection of breast cancer using total biochemical analysis of peripheral blood components: a preliminary study" (77) and "High-level expression of enzymatically active human Cu/Zn superoxide dismutase in Escherichia coli." (65).

Most cited papers
#PaperReleasedCitations
1 Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome* Roman Mylonas, Ilan Beer, Christian Iseli et al. · Molecular & Cellular Proteomics Open access 31 Aug 2018 98
2 Early detection of breast cancer using total biochemical analysis of peripheral blood components: a preliminary study Udi Zelig, Eyal Barlev, Omri Bar et al. · BMC Cancer Open access 14 May 2015 77
3 High-level expression of enzymatically active human Cu/Zn superoxide dismutase in Escherichia coli. John R. Hartman, Tania Geller, Ziva Yavin et al. · Proceedings of the National Academy of Sciences Open access Oct 1986 65
4 A versatile, automated and high-throughput drug screening platform for zebrafish embryos Alexandra Lubin, Jason Otterstrom, Yvette Hoade et al. · Biology Open Open access 12 Jul 2021 53
5 Expression and reconstitution of biologically active human acetylcholinesterase fromEscherichia coli Meir Fischer, Avner Ittah, Ilana Liefer et al. · Cellular and Molecular Neurobiology Open access Feb 1993 41
All 20 most cited papers, with filters and sorting

Which research topics does IDEA Bio-Medical (Israel) publish most on?

By volume in 2022-now: Zebrafish Biomedical Research Applications, Cell Image Analysis Techniques, Single-cell and spatial transcriptomics and Diet and metabolism studies.

  1. 1 Zebrafish Biomedical Research Applications Cell Biology 0 works
  2. 2 Cell Image Analysis Techniques Biophysics 0 works
  3. 3 Single-cell and spatial transcriptomics Molecular Biology 0 works
  4. 4 Diet and metabolism studies Physiology 0 works
  5. 5 Vascular Malformations and Hemangiomas Surgery 0 works
  6. 6 Islanding Detection in Power Systems Electrical and Electronic Engineering 0 works
  7. 7 CNS Lymphoma Diagnosis and Treatment Neurology 0 works
  8. 8 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  9. 9 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works
  10. 10 Indoor Air Quality and Microbial Exposure Health, Toxicology and Mutagenesis 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available56.4%not open43.6%

World: 40% of research is openly available.

with international co-authors36.3%domestic only63.7%

World: 18% is written across borders.

How has IDEA Bio-Medical (Israel)'s research output changed?

Output in 2022-2025 was 15% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is IDEA Bio-Medical (Israel) as a percentage of every work published that year, 0.0000045% in 2024.

still counting0.00010%0.00020%IDEA Bio-Medical (Israel)0.0000034% in 20251990200020102020

Fractional works of IDEA Bio-Medical (Israel) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Rehovot

All research institutions in Rehovot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about IDEA Bio-Medical (Israel). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.